Welcome to the first Equiduct en España newsletter.
January 2022
As this is our first newsletter, we would like to first recap some of our key milestones of 2021:
Here’s a summary of what we have seen in Equiduct over the month of January 2022 and Q4 2021
€467M ADV in Jan 2022
January’s ADV is already breaking Equiduct Q4 ADV of 2021 of over €340M
Spain = 8.5% of our ADV
Spain represents a total of 8.5% of our total ADV. In January, Spanish ADV reached €34M
49% market share growth
Equiduct’s market share in Spain grew by 49% in 2021 vs 2020
€6.5Bn turnover in Spain
In 2021, Spanish turnover reached €6.5 billion in Equiduct
Equiduct's ADV progression overall and in Spain
Our top traded Spanish stocks
Execution quality analysis of Spanish stocks on Equiduct
Q4 2021 data, obtained and analysed by smart data and analytics company, big xyt, which an independent
and fully neutral market data analytics provider.
Price formation on Equiduct (for Spanish instruments) uses liquidity available on BME, CBOE Europe,
Turquoise Europe and Equiduct’s own CLOB. As a result, execution prices on Equiduct will always be
better or equal to those achievable on BME.
Looking into the future
We have many new developments in our pipeline! We are looking forward to announcing soon
further geographical expansion of our universe and new exciting ETFs.
Download the newsletter in PDF format
The trading venue of tomorrow, today.
"We’re excited to have opened our office in Madrid in 2021, and we’re very optimistic about the potential for growth in Spain, and delighted with the response we’ve received so far from the Spanish market.
For 2022, we expect to see a substantial increase in participation from Spanish brokers in benefiting from our unique Best Execution offering for retail investors".
Luis Velasco, Country Head - Spain